Growing community of inventors

Lille, France

Philippe Klein

Average Co-Inventor Count = 4.85

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 37

Philippe KleinChristophe De Romeuf (4 patents)Philippe KleinEmmanuel Nony (4 patents)Philippe KleinNicolas Bihoreau (4 patents)Philippe KleinDominique Bourel (4 patents)Philippe KleinChristine Gaucher (4 patents)Philippe KleinSylvie Jorieux (4 patents)Philippe KleinChristian Behrens (1 patent)Philippe KleinDimitri Gueuning (1 patent)Philippe KleinBernard Poulaert (1 patent)Philippe KleinDenis Hoguet (1 patent)Philippe KleinChristine Gauchet (0 patent)Philippe KleinChristine Gauchet (0 patent)Philippe KleinChristine Gauchet (0 patent)Philippe KleinPhilippe Klein (6 patents)Christophe De RomeufChristophe De Romeuf (30 patents)Emmanuel NonyEmmanuel Nony (29 patents)Nicolas BihoreauNicolas Bihoreau (24 patents)Dominique BourelDominique Bourel (21 patents)Christine GaucherChristine Gaucher (11 patents)Sylvie JorieuxSylvie Jorieux (8 patents)Christian BehrensChristian Behrens (11 patents)Dimitri GueuningDimitri Gueuning (5 patents)Bernard PoulaertBernard Poulaert (1 patent)Denis HoguetDenis Hoguet (1 patent)Christine GauchetChristine Gauchet (0 patent)Christine GauchetChristine Gauchet (0 patent)Christine GauchetChristine Gauchet (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Laboratoire Francais Du Fractionnement Et Des Biotechnologies (5 from 85 patents)

2. Sonaca S.a. (1 from 19 patents)

3. Etat Francais Represente Par Le Directeur Central Du Service De Sante Des Armees (1 from 1 patent)


6 patents:

1. 10059760 - Immunoglobulin against the anthrax toxin

2. 9879089 - Use of ADCC-optimized antibodies for treating low-responder patients

3. 9662853 - Process for manufacturing a panel comprising at least one honeycomb body and a first skin made from a composite material

4. 9109020 - Use of ADCC-optimized antibodies for treating weak patients

5. 8501171 - Use of ADCC-optimized antibodies for treating weak patients

6. 7713524 - Use of ADCC-optimized antibodies for treating low-responder patients

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/11/2025
Loading…